O'Neill Thomas Garvey, Tsushima Takahiro, Tayal Bhupendar
Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
Department of Medicine, Division of Cardiology, University Hospitals Harrington Heart & Vascular Institute, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
J Clin Med. 2025 May 6;14(9):3212. doi: 10.3390/jcm14093212.
Left bundle branch block (LBBB), initially described in the early 20th century, has become increasingly recognized as one of the leading causes of advanced heart failure (HF). In addition to rapidly growing data on guideline-directed medical therapy, cardiac resynchronization therapy (CRT) via transvenous coronary sinus lead has been the gold-standard therapy, but one-third of the indicated patients do not receive the expected benefits. Recently, cardiac conduction system pacing (CSP) was identified as an alternative to traditional CRT strategy, and multiple data have been published during the last few years. This review will discuss the diagnostic criteria of LBBB and its relation to the development of HF and review available data for traditional CRT as well as CSP in depth.
左束支传导阻滞(LBBB)最早于20世纪初被描述,如今已日益被视为晚期心力衰竭(HF)的主要病因之一。除了关于指南指导下药物治疗的数据迅速增加外,经静脉冠状窦导联的心脏再同步治疗(CRT)一直是金标准治疗方法,但三分之一的适应症患者并未获得预期益处。最近,心脏传导系统起搏(CSP)被确定为传统CRT策略的替代方法,并且在过去几年中已经发表了多项数据。本综述将深入讨论LBBB的诊断标准及其与HF发展的关系,并回顾传统CRT以及CSP的现有数据。